{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:35:26Z","timestamp":1793090126347,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2026NSFSC0582"],"award-info":[{"award-number":["2026NSFSC0582"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470290"],"award-info":[{"award-number":["82470290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005622","name":"Health Research","doi-asserted-by":"publisher","award":["Chuanjianyan ZH2025-202"],"award-info":[{"award-number":["Chuanjianyan ZH2025-202"]}],"id":[{"id":"10.13039\/100005622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105612","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:41:06Z","timestamp":1789882866000},"page":"105612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomaterial-based mitochondria-targeted nanomedicine for remodeling the breast cancer tumor microenvironment and overcoming therapy resistance"],"prefix":"10.1016","volume":"227","author":[{"given":"Yao","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongze","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105612_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.01.004","article-title":"Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin","volume":"296","author":"Abumanhal-Masarweh","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105612_bib2","first-page":"15","article-title":"Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics","author":"Akinsipe","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1186\/s12885-019-6353-2","article-title":"CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy","volume":"19","author":"Alves WEFM","year":"2019","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105612_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.201308006","article-title":"The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission","volume":"204","author":"Anand","year":"2014","journal-title":"J. Cell. Biol."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105612_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41388-023-02596-8","article-title":"Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment","volume":"42","author":"Baek","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105612_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101993","article-title":"Activation of the eIF2\u03b1\/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis","volume":"43","author":"Bai","year":"2021","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105612_bib7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.apsb.2018.05.006","article-title":"Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives","volume":"8","author":"Battogtokh","year":"2018","journal-title":"Acta Pharm. Sin. B."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105612_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"717","key":"10.1016\/j.critrevonc.2026.105612_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2712","article-title":"Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy","volume":"15","author":"Cao","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105612_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100903","article-title":"Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells","volume":"41","author":"Carreira","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.critrevonc.2026.105612_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122745","article-title":"Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-\/immuno-therapy for cancer treatments","volume":"312","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105612_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.actbio.2023.07.060","article-title":"Endoplasmic reticulum-mitochondrial calcium transport contributes to soft extracellular matrix-triggered mitochondrial dynamics and mitophagy in breast carcinoma cells","volume":"169","author":"Chen","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.critrevonc.2026.105612_bib13","doi-asserted-by":"crossref","unstructured":"Cheriyan B.V., Nandhini J., Devaraji M. Nanotechnology-enabled platforms for breast cancer therapy: advances in biomaterials, drug delivery, and theranostics. Biomed Mater Devices. Published online September 9, 2025.","DOI":"10.1007\/s44174-025-00502-2"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105612_bib14","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/s12276-023-01114-w","article-title":"Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105612_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijms23042386","article-title":"Smart lipid\u2013polysaccharide nanoparticles for targeted delivery of doxorubicin to breast cancer cells","volume":"23","author":"Curcio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7354","key":"10.1016\/j.critrevonc.2026.105612_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105612_bib17","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s12274-020-2972-9","article-title":"Metal-polyphenol-network coated CaCO3 as pH-responsive nanocarriers to enable effective intratumoral penetration and reversal of multidrug resistance for augmented cancer treatments","volume":"13","author":"Dong","year":"2020","journal-title":"Nano Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105612_bib18","first-page":"1073","article-title":"MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches","volume":"32","author":"Dw","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib19","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1038\/s41467-023-40022-5","article-title":"Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers","volume":"14","author":"El-Botty","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105612_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13346-024-01669-9","article-title":"Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeation","volume":"15","author":"Famta","year":"2025","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105612_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1158\/0008-5472.CAN-18-3985","article-title":"Acquired resistance to HER2-targeted therapies creates vulnerability to ATP synthase inhibition","volume":"80","author":"Gale","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105612_bib22","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.2147\/IJN.S134148","article-title":"iRGD-modified lipid\u2013polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability","volume":"12","author":"Gao","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105612_bib23","article-title":"Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics","volume":"1880","author":"Garg","year":"2025","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/ijbc\/3013009","article-title":"Exploring the potential of mitochondria-targeted drug delivery for enhanced breast cancer therapy","volume":"2025","author":"Ghazizadeh","year":"2025","journal-title":"Int. J. Breast Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105612_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10911-020-09475-y","article-title":"Cancer-associated fibroblasts in the breast tumor microenvironment","volume":"26","author":"Giorello","year":"2021","journal-title":"J. Mammary Gland. Biol. Neoplasia"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib26","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1038\/s41467-024-51995-2","article-title":"Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-C","volume":"15","author":"Godet","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1186\/s12951-025-03815-y","article-title":"Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy","volume":"23","author":"Gong","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40364-024-00714-6","article-title":"Tumor microenvironment and immunotherapy for triple-negative breast cancer","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105612_bib29","first-page":"569","article-title":"Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance","volume":"14","author":"Han","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105612_bib30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/biom12111595","article-title":"Metabolic regulation of mitochondrial protein biogenesis from a neuronal perspective","volume":"12","author":"Hees","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105612_bib31","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.2147\/IJN.S474135","article-title":"iRGD-guided silica\/gold nanoparticles for efficient tumor-targeting and enhancing antitumor efficacy against breast cancer","volume":"19","author":"Hou","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"38","key":"10.1016\/j.critrevonc.2026.105612_bib32","doi-asserted-by":"crossref","first-page":"41258","DOI":"10.18632\/oncotarget.5692","article-title":"Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment","volume":"6","author":"Hu","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12951-024-02502-8","article-title":"Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction","volume":"22","author":"Hu","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12967-025-06077-2","article-title":"A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105612_bib35","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7150\/thno.47446","article-title":"Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105612_bib36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jconrel.2022.11.007","article-title":"Extracellular matrix degrading enzyme with stroma-targeting peptides enhance the penetration of liposomes into tumors","volume":"352","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105612_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tibs.2025.03.001","article-title":"Understanding mitochondrial protein import: a revised model of the presequence translocase","volume":"50","author":"Jain","year":"2025","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105612_bib38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/ph15101271","article-title":"The anti-cancer effects of mitochondrial-targeted triphenylphosphonium\u2013resveratrol conjugate on breast cancer cells","volume":"15","author":"Jiang","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105612_bib39","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s10943-023-01776-w","article-title":"Do divine struggles moderate the association between interpersonal conflict at work and worker well-being in Singapore?","volume":"63","author":"Jung","year":"2024","journal-title":"J. Relig. Health"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105612_bib40","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/cancers17101653","article-title":"Mechanisms and therapeutic strategies for endocrine resistance in breast cancer: a comprehensive review and meta-analysis","volume":"17","author":"Khan","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105612_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell. Metab."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105612_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell. Metab."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105612_bib43","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217991","article-title":"Inhibition of CPT1A activates the cGAS\/STING pathway to enhance neutrophil-mediated tumor abrogation in triple-negative breast cancer","volume":"633","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105612_bib45","first-page":"5865","article-title":"The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis","volume":"14","author":"Li","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105612_bib46","first-page":"16","article-title":"Tumor-derived extracellular vesicles: key drivers of immunomodulation in breast cancer","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105612_bib47","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1039\/D3BM00931A","article-title":"MnO2\/Ce6 microbubble-mediated hypoxia modulation for enhancing sono-photodynamic therapy against triple negative breast cancer","volume":"12","author":"Li","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.critrevonc.2026.105612_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2020.06.010","article-title":"A novel mitochondrial targeted hybrid peptide modified HPMA copolymers for breast cancer metastasis suppression","volume":"325","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib49","doi-asserted-by":"crossref","first-page":"25968","DOI":"10.1038\/srep25968","article-title":"IR-780 dye as a sonosensitizer for sonodynamic therapy of breast tumor","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105612_bib50","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.apsb.2020.10.009","article-title":"GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy","volume":"10","author":"Lin","year":"2020","journal-title":"Acta Pharm. Sin. B."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105612_bib51","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1007\/s11033-022-07802-6","article-title":"Acute vs. chronic vs. intermittent hypoxia in breast cancer: a review on its application in in vitro research","volume":"49","author":"Liu","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105612_bib52","first-page":"16","article-title":"An immunomodulatory photosensitizer-mediated photodynamic therapy synergizes with PD-L1 blockade against metastatic triple-negative breast cancer","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib53","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s12951-024-02945-z","article-title":"Dual-modal overcoming of physical barriers for improved photodynamic cancer therapy via soft organosilica nanocapsules","volume":"22","author":"Lu","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105612_bib54","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.3390\/ijms26135973","article-title":"Tumor-associated macrophage in breast tumor microenvironment","volume":"26","author":"Ma","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105612_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118224","article-title":"Nanotechnology-mediated precision drug delivery strategies for breast cancer treatment","volume":"188","author":"Maleki","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105612_bib56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/jpm11080754","article-title":"Breast cancer cell-derived adenosine enhances generation and suppressor function of human adaptive regulatory T cells","volume":"11","author":"Mandapathil","year":"2021","journal-title":"J. Pers. Med."},{"issue":"64","key":"10.1016\/j.critrevonc.2026.105612_bib57","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.18632\/oncotarget.27347","article-title":"Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study","volume":"10","author":"Martins","year":"2019","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105612_bib58","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.261608","article-title":"MCT4 and CD147 colocalize with MMP14 in invadopodia and support matrix degradation and invasion by breast cancer cells","volume":"137","author":"Meng","year":"2024","journal-title":"J. Cell. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105612_bib59","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1914510","article-title":"Trastuzumab deruxtecan in previously treated HER2-positive breast cancer","volume":"382","author":"Modi","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105612_bib60","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s12094-024-03793-x","article-title":"Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles","volume":"27","author":"Muhammad","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib61","first-page":"10","article-title":"Lactate metabolism and immune modulation in breast cancer: a focused review on triple negative breast tumors","author":"Naik","year":"2020","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105612_bib62","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1039\/D3NA00965C","article-title":"Nanoparticle-mediated diagnosis, treatment, and prevention of breast cancer","volume":"6","author":"Panigrahi","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105612_bib63","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s43018-023-00563-6","article-title":"Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases","volume":"4","author":"Parida","year":"2023","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib64","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12951-025-03569-7","article-title":"A GSH-consuming polymeric nanoparticles drives ferroptosis amplification and combines chemotherapy to amplify breast cancer treatment","volume":"23","author":"Pei","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105612_bib65","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105612_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10555-025-10264-4","article-title":"Lactate metabolism and lactylation in breast cancer: mechanisms and implications","volume":"44","author":"Qiao","year":"2025","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.critrevonc.2026.105612_bib67","article-title":"Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy","author":"Qin","year":"2021","journal-title":"Publ. Online"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105612_bib68","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.3390\/cancers15204931","article-title":"Immunotherapy enhancement by targeting extracellular tumor pH in triple-negative breast cancer mouse model","volume":"15","author":"Rahman","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105612_bib69","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/1878-0261.13437","article-title":"Investigating the contribution of hyaluronan to the breast tumour microenvironment using multiparametric MRI and MR elastography","volume":"17","author":"Reeves","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213456","article-title":"Erythrocyte\u2212cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer","volume":"151","author":"Rezaei","year":"2023","journal-title":"Biomater. Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib71","first-page":"39","article-title":"Mitochondrial dynamics in breast cancer metastasis: from metabolic drivers to therapeutic targets","volume":"3","author":"Ruidas","year":"2025","journal-title":"Oncol. Adv."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105612_bib72","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00109-021-02136-5","article-title":"Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies","volume":"99","author":"Saatci","year":"2021","journal-title":"J. Mol. Med."},{"issue":"38","key":"10.1016\/j.critrevonc.2026.105612_bib73","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","article-title":"Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1","volume":"269","author":"Semenza","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105612_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117402","article-title":"Glucose oxidase and MnO2 functionalized liposome for catalytic radiosensitization enhanced synergistic breast cancer therapy","volume":"179","author":"Shao","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11033-025-11231-6","article-title":"Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights","volume":"53","author":"Sharma","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105612_bib76","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.2147\/IJN.S163858","article-title":"Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes","volume":"13","author":"Shi","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"25","key":"10.1016\/j.critrevonc.2026.105612_bib77","doi-asserted-by":"crossref","first-page":"11607","DOI":"10.7150\/thno.46228","article-title":"Hemoglobin-mediated biomimetic synthesis of paramagnetic O2-evolving theranostic nanoprobes for MR imaging-guided enhanced photodynamic therapy of tumor","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105612_bib78","article-title":"Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: role of monocarboxylate transporter","volume":"1867","author":"Singh","year":"2021","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"issue":"4785","key":"10.1016\/j.critrevonc.2026.105612_bib79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105612_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216847","article-title":"Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics","volume":"590","author":"Song","year":"2024","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105612_bib81","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1007\/s00210-025-04039-5","article-title":"Innovative nanodelivery systems for targeted breast cancer therapy: overcoming drug delivery challenges and exploring future perspectives","volume":"398","author":"Su","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105612_bib82","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105612_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.107817","article-title":"Mitochondria-targeted cancer therapy based on functional peptides","volume":"34","author":"Sun","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cmet.2014.12.003","article-title":"Mitochondrial Genome Acquisition Restores Respiratory Function and Tumorigenic Potential of Cancer Cells without Mitochondrial DNA","volume":"21","author":"Tan","year":"2015","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105612_bib85","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.2147\/IJN.S508696","article-title":"Biomimetic self-oxygenated immunoliposome for cancer-targeted photodynamic immunotherapy","volume":"20","author":"Tang","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105612_bib86","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10495-022-01763-8","article-title":"DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients","volume":"27","author":"Vasiyani","year":"2022","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib87","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s11671-024-04122-5","article-title":"Tumor microenvironment\u2013responsive nanoformulations for breast cancer","volume":"19","author":"Velapure","year":"2024","journal-title":"Discov. Nano"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105612_bib88","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105612_bib89","first-page":"15","article-title":"The involvement and application potential of exosomes in breast cancer immunotherapy","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib90","doi-asserted-by":"crossref","unstructured":"Wang L., Zheng L., Yong X., et al. Activation of the cGAS\u2013STING pathway by clofoctol through mitochondrial damage in triple-negative breast cancer. J Transl Med. Published online December 22, 2025.","DOI":"10.1186\/s12967-025-07592-y"},{"key":"10.1016\/j.critrevonc.2026.105612_bib91","series-title":"Mitochondrial Medicine: Volume 1: Targeting Mitochondria","first-page":"13","article-title":"DQAsomes as the prototype of mitochondria-targeted pharmaceutical NanocarriersNanocarriers: an update","author":"Weissig","year":"2021"},{"issue":"7548","key":"10.1016\/j.critrevonc.2026.105612_bib92","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105612_bib93","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12032-025-03028-1","article-title":"Tumor microenvironment response to neoadjuvant therapy in breast cancer: insights from single-cell and spatial omics","volume":"42","author":"Wu","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib94","first-page":"45","article-title":"Intelligent delivery and clinical transformation of nanomedicine in breast cancer: from basic research to individualized therapy. Biofunctional Mater","volume":"23","author":"Wu","year":"2025","journal-title":"Publ. Online Oct."},{"key":"10.1016\/j.critrevonc.2026.105612_bib95","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12951-022-01416-7","article-title":"All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy","volume":"20","author":"Xie","year":"2022","journal-title":"J. Nanobiotechnolo."},{"key":"10.1016\/j.critrevonc.2026.105612_bib96","first-page":"15","article-title":"Dual regulation of the cGAS-STING pathway: new targets and challenges for subtype-specific immunotherapy in breast cancer","author":"Xiong","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib97","first-page":"13","article-title":"The role of matrix stiffness in breast cancer progression: a review","author":"Xu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.955127","article-title":"MnO2 coated multi-layer nanoplatform for enhanced sonodynamic therapy and MR imaging of breast cancer","volume":"10","author":"Xu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115390","article-title":"Targeting lactate metabolism in the tumor microenvironment: immunomodulation and prospects for antitumor therapy","volume":"164","author":"Yan","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib100","first-page":"1","article-title":"Multifunctional nanoparticles and collagenase dual loaded thermosensitive hydrogel system for enhanced tumor-penetration, reversed immune suppression and photodynamic-immunotherapy","volume":"48","author":"Yang","year":"2025","journal-title":"Bioact. Mater."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105612_bib101","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s11094-025-03301-7","article-title":"ML385 suppresses hypoxia-induced drug resistance and cancer stemness of breast cancer cells by blocking the Nrf2\/HO-1 pathway","volume":"58","author":"Yang","year":"2025","journal-title":"Pharm. Chem. J."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105612_bib102","first-page":"278","article-title":"Chemical inhibition of mitochondrial fission via targeting the DRP1-receptor interaction. Cell","volume":"30","author":"Yang","year":"2023","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib103","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12967-025-07370-w","article-title":"Recent progress in immune evasion mechanisms of triple-negative breast cancer","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105612_bib104","article-title":"Targeting mitochondria for cancer photodynamic therapy","volume":"38","author":"Yaqoob","year":"2022","journal-title":"Photo Photodyn. Ther."},{"key":"10.1016\/j.critrevonc.2026.105612_bib105","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211027836","article-title":"NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer","volume":"13","author":"Yuan","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105612_bib106","article-title":"Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.critrevonc.2026.105612_bib107","first-page":"55","article-title":"Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer","volume":"18","author":"Zhang","year":"2025","journal-title":"Nat. Commun. Publ. Online Dec."},{"key":"10.1016\/j.critrevonc.2026.105612_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123359","article-title":"Manganese-based nanoadjuvants for the synergistic enhancement of immune responses in breast cancer therapy via disulfidptosis-induced ICD and cGAS-STING activation","volume":"322","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105612_bib110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12967-025-06306-8","article-title":"Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105612_bib111","first-page":"15","article-title":"Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment","author":"Zhi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105612_bib112","first-page":"15","article-title":"Targeting metabolism of breast cancer and its implications in T cell immunotherapy","author":"Zou","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:50:25Z","timestamp":1793087425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":112,"alternative-id":["S1040842826004993"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105612","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomaterial-based mitochondria-targeted nanomedicine for remodeling the breast cancer tumor microenvironment and overcoming therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105612"}}